Physician profile
John L Mansell
NPI 1972535227
$5,019.36
in general payments reported to CMS, 2019-2025
12 companies · $1,954 in 2025
The $1,954 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.67 · 2020: $116 · 2021: $19.61 · 2023: $2,628 · 2024: $221 · 2025: $1,954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,901 · Food and Beverage: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,901.01 |
| Food and Beverage | $901.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,877.51 | 2023-2025 | Evoke Scs, Evoke |
| Mml US, INC. | $1,160.87 | 2025 | Reactiv8 |
| Medtronic, INC. | $535.21 | 2025 | Intellis Adaptivestim, Synchromedii |
| Abbott Laboratories | $272.81 | 2019-2025 | Eterna |
| Curonix LLC | $50.33 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $30.35 | 2024 | Intracept |
| Nevro Corp. | $24.35 | 2024 | Senza |
| Baxter Healthcare | $19.61 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.85 | 2025 | |
| Janssen Biotech, INC. | $13.89 | 2025 | Tremfya |
| Supernus Pharmaceuticals, INC. | $11.10 | 2019 | |
| Lifenet Health | $8.48 | 2024 | Flexigraft Connect, Graftlink, Duallink |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mansell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.